首页 > 快讯 > 正文

Novo Nordisk shares tumbled 23 per cent, their biggest one-day fall in 22 years, after a trial of its weight-loss drug CagriSema fell short of expectations.

clock
2024-12-20 19:00:02
Novo Nordisk shares tumbled 23 per cent, their biggest one-day fall in 22 years, after a trial of its weight-loss drug CagriSema fell short of expectations.